Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.82	10.71	2.43	5.9	12.11	29.21
Cash & Short-Term Investments	7.82	10.71	2.43	5.9	12.11	29.21
Cash Growth	334.87%	339.92%	-58.74%	-51.27%	-58.56%	162.75%
Other Receivables	-	-	-	-	1.61	-
Total Trade Receivables	-	-	-	-	1.61	-
Other Current Assets	0.54	0.28	0.55	0.62	0.8	0.95
Total Current Assets	8.36	10.99	2.99	6.52	14.52	30.16
Net Property, Plant & Equipment	0.04	0.04	-	-	-	-
Goodwill	-	-	-	-	-	8.87
Other Long-Term Assets	0.03	0.03	0.04	0.07	0.13	1.8
Total Assets	8.42	11.06	3.02	6.59	14.65	40.83
Accounts Payable	0.94	0.94	0.94	0.6	2.86	1.54
Accrued Expenses	0.24	0.86	0.35	0.41	1.41	0.57
Short-Term Debt	-	-	0.22	0.29	-	-
Unearned Revenue	3.23	3.23	-	-	-	-
Other Current Liabilities	0.14	0.14	-	-	-	-
Total Current Liabilities	4.55	5.17	1.51	1.3	4.27	2.11
Total Liabilities	4.55	5.17	1.51	1.3	4.27	2.11
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	100.54	100.33	83.44	81.64	74.19	70.92
Retained Earnings	-96.67	-94.44	-81.92	-76.35	-63.81	-32.2
Shareholders' Equity	3.88	5.89	1.51	5.29	10.38	38.72
Total Liabilities & Equity	8.42	11.06	3.02	6.59	14.65	40.83
Total Debt	-	0	0.22	0.29	0	0
Net Cash (Debt)	7.82	10.71	2.21	5.61	12.11	29.21
Net Cash Growth	-26.98%	384.03%	-60.56%	-53.66%	-58.56%	174.53%
Net Cash Per Share	34.55	110.45	27.59	2474.67	8205.73	203397.57
Book Value	3.88	5.89	1.51	5.29	10.38	38.72
Book Value Per Share	17.13	60.73	18.85	2332.20	7038.72	269599.00
Tangible Book Value	3.88	5.89	1.51	5.29	10.38	29.86
Tangible Book Value Per Share	17.13	60.73	18.85	2332.20	7038.72	207872.00

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.